XML 30 R19.htm IDEA: XBRL DOCUMENT v3.21.2
STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Tables)
6 Months Ended
Jun. 30, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of stock option activity

Determining the appropriate fair value of stock-based awards requires the input of subjective assumptions. The Company uses the Black-Scholes option pricing model to value its stock option awards. The assumptions used in calculating the fair value represent management’s best estimates and involve inherent uncertainties and judgements.

Options Outstanding

 

Weighted -

 

Average

Aggregate

 

Remaining

Intrinsic

 

Weighted-

Contractual

Value

 

Number of

Average

Term

(in 000’s)

 

Shares

Exercise Price

(in years)

(1)

 

Balance as of December 31, 2020

473,771

$

4.48

 

 

 

Granted

-

-

 

 

 

Forfeited/Cancelled/Expired

(8,300

)

9.72

 

 

 

Balance as of June 30, 2021

465,471

$

4.38

 

 

 

Exercisable as of June 30, 2021

465,471

$

4.38

4.38

$

329

 

 

(1)

The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company’s common stock for options that were in-the-money at each respective period.

Schedule of summary for the activities of unvested stock options

The following table summarizes the activities for the Company’s unvested stock options for the six months ended June 30, 2021:

14


Unvested Options

 

 

 

Weighted - Average

 

Number of Unvested Options

Grant Date

Exercise Price

 

Balance as of December 31, 2020

10,000

$

9.75

 

 

 

Vested

(10,000

)

9.75

 

 

 

Balance as of June 30, 2021

-

$

-

 

Schedule of warrant activity

The following table summarizes the activities for the Company’s warrants for the three months ended June 30, 2021:

Warrants Outstanding

Number of

Shares

Weighted-

Average

Exercise

Price

Weighted -

Average

Remaining

Contractual

Term in years)

Aggregate

Intrinsic

Value

(in 000's) (1)

 

Balance as of December 31, 2020

3,779,243

$

5.89

 

 

 

Granted

-

-

 

 

 

Balance as of June 30, 2021

3,779,243

$

5.89

3.5

 

 

 

Exercisable as of June 30, 2021

3,779,243

$

5.89

3.5

$

-

 

 

(1)

The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the closing stock price of $4.22 for our common stock on June 30, 2021.